Maria del Carmen Behrens

Assistant Professor

  • 7976 Citations
  • 51 h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Maria del Carmen Behrens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Mutation Medicine & Life Sciences
Survival Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2019

  • 7976 Citations
  • 51 h-Index
  • 167 Article
  • 5 Comment/debate
  • 3 Review article
  • 1 Conference contribution
1 Citation (Scopus)

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

Martínez-Terroba, E., Behrens, M. D. C., Agorreta, J., Monsó, E., Millares, L., Felip, E., Rosell, R., Ramirez, J. L., Remirez, A., Torre, W., Gil-Bazo, I., Idoate, M. A., De-Torres, J. P., Pio, R., Wistuba, I. I., Pajares, M. J. & Montuenga, L. M., Apr 1 2019, In : Thorax. 74, 4, p. 371-379 9 p.

Research output: Contribution to journalArticle

Neoplasm Staging
Squamous Cell Carcinoma
Lung
Proteins
Disease-Free Survival
2 Citations (Scopus)

Driver mutations in normal airway epithelium elucidate spatiotemporal resolution of lung cancer

Kadara, H. N., Sivakumar, S., Jakubek, Y., Anthony San Lucas, F., Lang, W., McDowell, T., Weber, Z., Behrens, M. D. C., Davies, G. E., Kalhor, N., Moran, C., El-Zein, R., Mehran, R. J., Swisher, S. G., Wang, J., Zhang, J., Fujimoto, J., Fowler, J., Heymach, J. V., Dubinett, S. & 4 others, Spira, A. E., Ehli, E. A., Wistuba, I. I. & Scheet, P. A., Sep 15 2019, In : American journal of respiratory and critical care medicine. 200, 6, p. 742-750 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Epithelium
Mutation
Allelic Imbalance
1 Citation (Scopus)

Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network

Román, M., López, I., Guruceaga, E., Baraibar, I., Ecay, M., Collantes, M., Nadal, E., Vallejo, A., Cadenas, S., Miguel, M. E., Jang, J. H., Martin-Uriz, P. S., Castro-Labrador, L., Vilas-Zornoza, A., Lara-Astiaso, D., Ponz-Sarvise, M., Rolfo, C., Santos, E. S., Raez, L. E., Taverna, S. & 5 others, Behrens, M. D. C., Weder, W., Wistuba, I. I., Vicent, S. & Gil-Bazo, I., Jan 1 2019, In : Cancer Research. 79, 3, p. 625-638 14 p.

Research output: Contribution to journalArticle

Maintenance
Neoplasm Metastasis
Survival
Adenocarcinoma of lung
Oncogenes

Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer

Shi, B., Behrens, M. D. C., Vaghani, V., Riquelme, E. M., Rodriguez-Canales, J., Kadara, H. N., Lin, H., Lee, J., Liu, H., Wistuba, I. I. & Simon, G., Jan 1 2019, (Accepted/In press) In : Cancer medicine.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Histone Deacetylases
Histone Deacetylase Inhibitors
Cell Line
Enhancer of Zeste Homolog 2 Protein
2 Citations (Scopus)

Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non–small cell lung cancer

MD Anderson Lung Cancer Immune Microenvironment Working Group, Sep 1 2019, In : Journal of Thoracic and Cardiovascular Surgery. 158, 3, p. 911-919.e6

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cell Proliferation
Inducible T-Cell Co-Stimulator Protein
Indoleamine-Pyrrole 2,3,-Dioxygenase
Neoplasms